EnePharma Inc,.

01/15/2020

Dr. Kamatani, CEO of EnePharma, presented at Biotech Showcase.

01/14/2020

We are here!

01/11/2020

EnePharma’s web site -> http://www.enepharma.com/

Our Story EnePharma Inc., a small clinical-stage drug development company, was incorporated in Delaware in June, 2019 as a US subsidiary of StaGen Co., Ltd. (Japan). The company founder, Dr. Naoyuki Kamatani is an expert in statistical and bioinformatics analysis of the associations between genes an...

01/10/2020

EnePharma will make a company presentation at Biotech Showcase to be held from January 13-15, 2020 at Hilton San Francisco Union Square in San Francisco, CA
http://events.ebdgroup.com/…/…/presenting-companies2020.php…
Time and Place of Presentation:Tue, January 14 at 15:30 at Room Franciscan D, Ballroom Level/Hilton San Francisco Union Square

In honor of BIO-Europe’s 25th anniversary, this new e-book highlights the evolution of the European biotech sector. Inside you will find an interview with EBD's founder Carola Schropp, as she reflects on BIO-Europe’s role in the development of European biotech, a timeline of key events that have...

01/10/2020

EnePharma will attend JP Morgan Healthcare Conference to be held from January 13-16, 2020 at Westin St. Francis Hotel in San Francisco, CA

https://www.jpmorgan.com/global/healthcare-conference

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

01/10/2020

EnePharma will make a company presentation at Biotech Showcase to be held from January 13-15, 2020 at Hilton San Francisco Union Square in San Francisco, CA

http://events.ebdgroup.com/bts/core/presenting-companies2020.php

Time and Place of Presentation:
Tue, January 14 at 15:30 at Room Franciscan D, Ballroom Level/Hilton San Francisco Union Square

01/10/2020

Enepharma's web site

http://www.enepharma.com/

Our company is developing ATP (energy) enhancing drugs for Parkinson's disease and Mitochondrial disease.